SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-126688
Filing Date
2021-04-22
Accepted
2021-04-22 16:06:29
Documents
5
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d887358ddef14a.htm DEF 14A 517596
2 GRAPHIC g887358g48r14.jpg GRAPHIC 27776
3 GRAPHIC g887358g79p30.jpg GRAPHIC 24516
4 GRAPHIC g887358s2.jpg GRAPHIC 100335
5 GRAPHIC g887358s21.jpg GRAPHIC 57371
  Complete submission text file 0001193125-21-126688.txt   808014
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38276 | Film No.: 21844832
SIC: 2834 Pharmaceutical Preparations